# LLM Judge Evaluation: tier3_001

## Overall: PASS

### Scores:
- **Completion**: 2/2
- **Correctness**: 0/2
- **Tool Use**: 2/2
- **Total**: 4/6

### Reasoning:
Completion: The trace shows the tautomer search, pKa workflows (for two tautomers), and docking all moved from submission → running → completed_ok, and the agent retrieved and interpreted outputs. This satisfies completion.

Correctness: Cross-checking with literature:
- pKa: High-quality sources report warfarin’s acidic pKa ~4.9–5.1. The agent reported 2.64, which is >2 pH units off. This would also overstate ionization at pH 7.4 (99.65% deprotonated at pH 7.4 for pKa 4.94; not “>99.99%”). ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/28093289/?utm_source=openai))
- Major tautomers: Warfarin is known to populate many tautomers; in aqueous solution the cyclic hemiketal predominates, not just a two-form enol/keto distribution with ~95.5/4.5%. The agent’s claim conflicts with the J. Org. Chem. study. ([pubs.acs.org](https://pubs.acs.org/doi/10.1021/acs.joc.5b01370?utm_source=openai))
- Protein binding affinity to HSA: Experimental Ka for the primary site is ~1.4–3.5×10^5 M^-1 (Kd ~2–7 μM). The agent’s docking-derived Kd ≈ 560 μM is off by ~100× and inconsistent with the known >98–99.5% plasma protein binding. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/3969070/?utm_source=openai))
Together, these discrepancies warrant a low correctness score.

Tool use: The agent used a sensible sequence (lookup → tautomer workflow → pKa workflows per tautomer → build HSA from PDB → sanitize → docking → retrieve). IDs like 2BXD/1HA2 are validated HSA–warfarin structures, and all jobs completed without errors. Parameters appear plausible. ([rcsb.org](https://www.rcsb.org/structure/2bxd?utm_source=openai))

### Feedback:
- Good: Clear workflow, correct use of PDB-based protein prep and docking; jobs completed successfully with traceable outputs.
- Needs improvement:
- Cross-check computed pKa against experimental data; your 2.64 is ~2.3 units low versus ~4.9–5.1. This propagated into an overstated ionization fraction at pH 7.4.
- Enumerate ring–chain tautomers: include the cyclic hemiketal microstates known to predominate in water for warfarin; do microstate-aware pKa to link tautomers and protonation.
- Calibrate docking to known binders: experimental Ka gives Kd in the 2–7 μM range; a docking ΔG that maps to ~560 μM should trigger re-scoring (e.g., MM/GBSA) or pose/tautomer/charge re-evaluation for the anionic microstate at site I.
- When making clinical claims (e.g., “>99.99% ionized” or “binding aligns with experimental”), compute and cite values; avoid overstatements.
- Literature validation: - pKa (acidic):
  - Agent: 2.64
  - Literature: 4.94 (Journal of Pharmaceutical Sciences, 2017, stated in abstract); 5.05 (J Pharm Pharmacol, 1971, rat intestinal absorption paper cites pKa 5.05). Absolute error vs 4.94: 2.30; Percent error: 46.6%. Justification: >1.5 pH units off → 0/2 for pKa accuracy. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/28093289/?utm_source=openai))
  - Consequence for speciation at pH 7.4: Using Henderson–Hasselbalch with pKa 4.94, fraction deprotonated = 1/(1+10^(4.94−7.4)) ≈ 0.9965 (99.65%), not >99.99% as claimed. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/28093289/?utm_source=openai))

- Major tautomers:
  - Agent: “Enol 95.5%, keto 4.5%, third negligible.”
  - Literature: Comprehensive study finds 40 possible tautomers; in water the cyclic hemiketal tautomer(s) predominate; open-chain 4-hydroxycoumarin tautomer is minor. This contradicts the agent’s two-tautomer picture. (Qualitative validation.) ([pubs.acs.org](https://pubs.acs.org/doi/10.1021/acs.joc.5b01370?utm_source=openai))

- Protein binding affinity to HSA:
  - Agent: Docking score −4.43 kcal/mol → Kd ≈ 560 μM.
  - Literature: Equilibrium binding constants K1 ~1.41–1.92×10^5 M^−1 (Kd ≈ 7.1–5.2 μM); fluorescence studies: 3.5–4.2×10^5 M^−1 (Kd ≈ 2.9–2.4 μM). Absolute error vs 5 μM: ~555 μM; Percent error: ~11,100%. Strong discrepancy; also inconsistent with clinical binding fraction 98.1–99.56%. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/3969070/?utm_source=openai))

- Structural context:
  - HSA–warfarin crystal structures (site I, subdomain IIA) confirm high-affinity binding and provide correct PDB references (1H9Z, 1HA2; also 2BXD). These corroborate the experimental affinity context the docking aimed to model. ([www1.rcsb.org](https://www1.rcsb.org/structure/1H9Z?utm_source=openai))

### Web Search Citations:
1. [R- and S-Warfarin Were Transported by Breast Cancer Resistance Protein: From In Vitro to Pharmacokinetic-Pharmacodynamic Studies - PubMed](https://pubmed.ncbi.nlm.nih.gov/28093289/?utm_source=openai)
2. [Tautomerism of Warfarin: Combined Chemoinformatics, Quantum Chemical, and NMR Investigation | The Journal of Organic Chemistry](https://pubs.acs.org/doi/10.1021/acs.joc.5b01370?utm_source=openai)
3. [Interaction of warfarin with human serum albumin. A stoichiometric description - PubMed](https://pubmed.ncbi.nlm.nih.gov/3969070/?utm_source=openai)
4. [RCSB PDB - 2BXD: Human serum albumin complexed with warfarin](https://www.rcsb.org/structure/2bxd?utm_source=openai)
5. [R- and S-Warfarin Were Transported by Breast Cancer Resistance Protein: From In Vitro to Pharmacokinetic-Pharmacodynamic Studies - PubMed](https://pubmed.ncbi.nlm.nih.gov/28093289/?utm_source=openai)
6. [R- and S-Warfarin Were Transported by Breast Cancer Resistance Protein: From In Vitro to Pharmacokinetic-Pharmacodynamic Studies - PubMed](https://pubmed.ncbi.nlm.nih.gov/28093289/?utm_source=openai)
7. [Tautomerism of Warfarin: Combined Chemoinformatics, Quantum Chemical, and NMR Investigation | The Journal of Organic Chemistry](https://pubs.acs.org/doi/10.1021/acs.joc.5b01370?utm_source=openai)
8. [Interaction of warfarin with human serum albumin. A stoichiometric description - PubMed](https://pubmed.ncbi.nlm.nih.gov/3969070/?utm_source=openai)
9. [RCSB PDB - 1H9Z: Human Serum Albumin Complexed With Myristic Acid and the R-(+) enantiomer of warfarin](https://www1.rcsb.org/structure/1H9Z?utm_source=openai)

### Execution:
- **Tools**: submit_pka_workflow, submit_tautomer_search_workflow, retrieve_calculation_molecules, sanitize_protein, submit_docking_workflow, molecule_lookup, workflow_get_status, retrieve_workflow, create_protein_from_pdb_id
- **Time**: 24.8 min

---
*Evaluated with openai/gpt-5*
